Corning Clinical Laboratories to use AutoPap system:
This article was originally published in Clinica
Executive Summary
Corning Clinical Laboratories is to use NeoPath's recently approved AutoPap 300 QC system as part of its quality control for rescreening Pap smears in its 25 testing facilities in the US. The first instruments are expected to be operating at the company's Chicago facility in January 1996. The agreement with Corning follows an earlier decision by SmithKline Beecham to use AutoPap in its clinical laboratories (see Clinica No 675, p 16).